These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30610833)

  • 21. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
    Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
    Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and demographic predictors of mild cognitive impairment for converting to Alzheimer's disease and reverting to normal cognition.
    Tokuchi R; Hishikawa N; Kurata T; Sato K; Kono S; Yamashita T; Deguchi K; Abe K
    J Neurol Sci; 2014 Nov; 346(1-2):288-92. PubMed ID: 25248955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patterns of longitudinal cortical atrophy over 3 years in empirically derived MCI subtypes.
    Edmonds EC; Weigand AJ; Hatton SN; Marshall AJ; Thomas KR; Ayala DA; Bondi MW; McDonald CR;
    Neurology; 2020 Jun; 94(24):e2532-e2544. PubMed ID: 32393648
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors predicting reversion from mild cognitive impairment to normal cognitive functioning: a population-based study.
    Sachdev PS; Lipnicki DM; Crawford J; Reppermund S; Kochan NA; Trollor JN; Wen W; Draper B; Slavin MJ; Kang K; Lux O; Mather KA; Brodaty H;
    PLoS One; 2013; 8(3):e59649. PubMed ID: 23544083
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of the IWG-2 Diagnostic Criteria for Alzheimer's Disease to the ADNI.
    Wang HF; Tan L; Cao L; Zhu XC; Jiang T; Tan MS; Liu Y; Wang C; Tsai RM; Jia JP; Yu JT;
    J Alzheimers Dis; 2016; 51(1):227-36. PubMed ID: 26836176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evidence for the Utility of Actuarial Neuropsychological Criteria Across the Continuum of Normal Aging, Mild Cognitive Impairment, and Dementia.
    Graves LV; Edmonds EC; Thomas KR; Weigand AJ; Cooper S; Bondi MW
    J Alzheimers Dis; 2020; 78(1):371-386. PubMed ID: 32986674
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of Normative Adjustments to the Montreal Cognitive Assessment.
    Pugh EA; Kemp EC; van Dyck CH; Mecca AP; Sharp ES;
    Am J Geriatr Psychiatry; 2018 Dec; 26(12):1258-1267. PubMed ID: 30314940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between CSF biomarkers, hippocampal volume and cognitive function in patients with amnestic mild cognitive impairment (MCI).
    Nathan PJ; Lim YY; Abbott R; Galluzzi S; Marizzoni M; Babiloni C; Albani D; Bartres-Faz D; Didic M; Farotti L; Parnetti L; Salvadori N; Müller BW; Forloni G; Girtler N; Hensch T; Jovicich J; Leeuwis A; Marra C; Molinuevo JL; Nobili F; Pariente J; Payoux P; Ranjeva JP; Rolandi E; Rossini PM; Schönknecht P; Soricelli A; Tsolaki M; Visser PJ; Wiltfang J; Richardson JC; Bordet R; Blin O; Frisoni GB;
    Neurobiol Aging; 2017 May; 53():1-10. PubMed ID: 28189924
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
    Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
    Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuropsychological Equivalence of the Clinical Diagnosis of Mild Cognitive Impairment in the National Alzheimer's Coordinating Center Uniform Data Set and Alzheimer's Disease Neuroimaging Initiative.
    Kiselica AM; Benge JF;
    Dement Geriatr Cogn Disord; 2021; 50(3):231-236. PubMed ID: 34186536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combining Cerebrospinal Fluid Biomarkers and Neuropsychological Assessment: A Simple and Cost-Effective Algorithm to Predict the Progression from Mild Cognitive Impairment to Alzheimer's Disease Dementia.
    Mazzeo S; Santangelo R; Bernasconi MP; Cecchetti G; Fiorino A; Pinto P; Passerini G; Falautano M; Comi G; Magnani G
    J Alzheimers Dis; 2016 Oct; 54(4):1495-1508. PubMed ID: 27589522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of the Spanish version of the Everyday Cognition scale in the diagnosis of mild cognitive impairment and mild dementia in an older cohort from the Argentina-ADNI.
    Russo MJ; Cohen G; Chrem Mendez P; Campos J; Martín ME; Clarens MF; Tapajoz F; Harris P; Sevlever G; Allegri RF
    Aging Clin Exp Res; 2018 Oct; 30(10):1167-1176. PubMed ID: 29380265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of Reversion from Mild Cognitive Impairment to Normal Cognition.
    Pandya SY; Lacritz LH; Weiner MF; Deschner M; Woon FL
    Dement Geriatr Cogn Disord; 2017; 43(3-4):204-214. PubMed ID: 28301848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type.
    Popp J; Wolfsgruber S; Heuser I; Peters O; Hüll M; Schröder J; Möller HJ; Lewczuk P; Schneider A; Jahn H; Luckhaus C; Perneczky R; Frölich L; Wagner M; Maier W; Wiltfang J; Kornhuber J; Jessen F
    Neurobiol Aging; 2015 Feb; 36(2):601-7. PubMed ID: 25435336
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of cerebrospinal fluid Neurogranin with Alzheimer's disease.
    Wang L;
    Aging Clin Exp Res; 2019 Feb; 31(2):185-191. PubMed ID: 29667155
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Longitudinal Trajectories of Informant-Reported Daily Functioning in Empirically Defined Subtypes of Mild Cognitive Impairment.
    Thomas KR; Edmonds EC; Delano-Wood L; Bondi MW
    J Int Neuropsychol Soc; 2017 Jul; 23(6):521-527. PubMed ID: 28487004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association between Cerebrospinal Fluid Biomarkers for Alzheimer's Disease, APOE Genotypes and Auditory Verbal Learning Task in Subjective Cognitive Decline, Mild Cognitive Impairment, and Alzheimer's Disease.
    Mandecka M; Budziszewska M; Barczak A; Pepłońska B; Chodakowska-Żebrowska M; Filipek-Gliszczyńska A; Nesteruk M; Styczyńska M; Barcikowska M; Gabryelewicz T
    J Alzheimers Dis; 2016 Jul; 54(1):157-68. PubMed ID: 27472875
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer's disease patients: a retrospective observational study.
    Scaricamazza E; Colonna I; Sancesario GM; Assogna F; Orfei MD; Franchini F; Sancesario G; Mercuri NB; Liguori C
    Neurol Sci; 2019 Jul; 40(7):1377-1382. PubMed ID: 30903419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Word-list intrusion errors predict progression to mild cognitive impairment.
    Thomas KR; Eppig J; Edmonds EC; Jacobs DM; Libon DJ; Au R; Salmon DP; Bondi MW;
    Neuropsychology; 2018 Feb; 32(2):235-245. PubMed ID: 29528684
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Brief Neuropsychological Assessment, Amnestic Mild Cognitive Impairment (MCI) Is associated with Cerebrospinal Fluid Biomarkers for Cognitive Decline in Contrast to the Prevailing NIA-AA MCI Criterion.
    Hessen E; Kirsebom BE; Eriksson CM; Eliassen CF; Nakling AE; Bråthen G; Waterloo KK; Aarsland D; Fladby T
    J Alzheimers Dis; 2019; 67(2):715-723. PubMed ID: 30614807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.